Cargando…
Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by a severe ADAMTS13 deficiency due to the presence of anti-ADAMTS13 auto-antibodies, with subsequent accumulation of circulating ultra-large von Willebrand factor (VWF) multimers. The role of endothelial cell activation as...
Autores principales: | Tellier, Edwige, Widemann, Agnès, Cauchois, Raphaël, Faccini, Julien, Lagarde, Marie, Brun, Marion, Robert, Philippe, Robert, Stéphane, Bachelier, Richard, Poullin, Pascale, Roose, Elien, Vanhoorelbeke, Karen, Coppo, Paul, Dignat-George, Françoise, Kaplanski, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071132/ https://www.ncbi.nlm.nih.gov/pubmed/36453103 http://dx.doi.org/10.3324/haematol.2022.280651 |
Ejemplares similares
-
Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?
por: Cauchois, Raphael, et al.
Publicado: (2023) -
Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
por: Kangro, Kadri, et al.
Publicado: (2020) -
ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology
por: Joly, Bérangère S., et al.
Publicado: (2022) -
Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab
por: Völker, Linus A., et al.
Publicado: (2020) -
Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019
Publicado: (2022)